Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1994-11-04
1996-10-15
Dodson, Shelley A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514120, 514859, 514880, 558 86, 558231, 560264, A61K 3166
Patent
active
055654398
ABSTRACT:
The subject invention involves a method for treating hyperproliferative conditions in mammalian epithelial cells comprising administering to the mammal a composition containing a safe and effective amount of a lysophosphatidic acid compound or derivative having the structure ##STR1## or a cyclic derivative thereof having the structure ##STR2## or a pharmaceutically acceptable salt thereof, wherein: a) --Y-- is --0-- or --CH.sub.2 --;
REFERENCES:
patent: 4876381 (1989-10-01), Lang et al.
Berdel, W., "Antineoplastic Activity of Synthetic Lysopholipid Analogs", Blut, vol. 44, pp. 71-78 (1982).
Glick, A., et al., "Retinoic Acid Induces Transforming Growth Factor-.beta.2 in Cultured Keratinocycles and Mouse Epidermis", Cell Regulation, vol. 1, pp. 87-97 (1989).
Herrmann, D., et al., "Phase I Trial of the Thioether Phospholipid Analogue BM 41.440 in Cancer Patients", Lipids, vol. 22, pp. 954-962 (1987).
Lippmann, et al., "Recent Advances in Cancer Chemoprevention", Cancer Cells, vol. 3, pp. 59-65 (1991).
Moon, R., et al., "Retinoids and Cancer", The Retinoids, vol. 2, pp. 327-371 (1984).
Munder, P., et al., "Alkyllsyophospholipids in Cancer Therapy", Augmenting Agents in Cancer Therapy, pp. 441-458 (1981).
Piazza, G., et al., "Involvement of Transforming Growth Factor-Alpha in the Proliferative Response of Cultured Human Epidermal Cells to Retinoic Acid", Clinical Research, vol. 39, p. 519 (1991) (Abstract).
Sporn, M., "Carcinogensis and Cancer: Different Perspectives on the Same Disease", Cancer Research, vol. 51, pp. 6215-6218 (1991).
Sporn, M., et al., "Chemoprevention of Cancer with Retinoids", Federation Proceedings, vol. 38, pp. 2528-2534 (1979).
Mazur Adam W.
Piazza Gary A.
Dodson Shelley A.
Graff IV Milton B.
Howell John M.
Suter David L.
The Procter & Gamble & Company
LandOfFree
Methods of using lysophosphatidic acid for treating hyperprolife does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of using lysophosphatidic acid for treating hyperprolife, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using lysophosphatidic acid for treating hyperprolife will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246177